Healthy adults
Conditions
Interventions
The bacillus sample is gathered from the inguinal region on the bacillus sample collection day.
Sponsors
Bio-Iatoric Center, Research Center for Clinical Pharmacology Kitasato University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1)Not younger than 20 on the day of informed consent (2)Be able to provide written informed consent (3)With healthy dermatological condition, as follows, at the test site -No dermatopathy, such as eczema, dermatitis, or abnormal pigmentation -No wounds or scars -No inflammation due to sunburn -No history of hypersensitivity to drugs -No abnormalities at the test site
Exclusion criteria
Exclusion criteria: (1)With a medical history of skin allergies such as contact dermatitis and atopic dermatitis (2)Received the investigational drug, unapproved drugs, or any treatment using unapproved medical device within 16 weeks prior to informed consent (3)Bathed in swimming pool or public bath within 2 weeks prior to informed consent (4)Bathed in hot tub or took a shower on the day before the bacterial sample collection (5)Received antibacterial drugs, antibiotics, steroids, or other medicine including OTC drugs that might affect the resident bacterial flora of normal skin within 1 week prior to the bacterial sample collection day. (6)Being pregnant, lactating, or at a risk of pregnancy (7)Not willing to contraception (8)Deemed ineligible for participation in the study in the investigator's or the co-investigator's opinion In the criteria of (2), (3) and (5)the day of informed consent or the day of bacterial sample collection is not included in the specified period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bacterial count in the bacterial sample | — |
Countries
Japan
Contacts
Public ContactTomoko Hasunuma
Bio-Iatoric Center, Research Center for Clinical Pharmacology Bio-Iatoric Center
Outcome results
None listed